Search
for

    Sort by

    Research 30 of 1000+

    1. Experimental and early investigational drugs for androgenetic alopecia Expert Opinion on Investigational Drugs · 2017 · 11 citations
    2. The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study Annals of Dermatology · 2012 · 21 citations
    3. Alfatradiol (0,025 %) - Eine wirksame und sichere Therapieoption zur Behandlung der androgenetischen Alopezie bei Frauen und Männern Aktuelle Dermatologie · 2005 · 10 citations
    4. Design and Validation of a Sensitive Multisteroid LC-MS/MS Assay for the Routine Clinical Use: One-Step Sample Preparation with Phospholipid Removal and Comparison to Immunoassays International Journal of Molecular Sciences · 2022 · 9 citations
    5. Guidelines for management of androgenetic alopecia based on BASP classification-the Asian consensus committee guideline Journal of The European Academy of Dermatology and Venereology · 2012 · 29 citations
    6. Female pattern hair loss Indian Journal of Dermatology, Venereology and Leprology · 2013 · 23 citations
    7. Androgenetic alopecia; drug safety and therapeutic strategies Expert Opinion on Drug Safety · 2018 · 20 citations
    8. Hormone und Haarwachstum Hautarzt · 2010 · 24 citations
    9. Androgenisierung Gynäkologische Endokrinologie · 2012 · 1 citations
    10. Female pattern alopecia: current perspectives International Journal of Women's Health · 2013 · 42 citations
    11. Review of the effects of 17α-estradiol in humans: a less feminizing estrogen with neuroprotective potential Drug Development Research · 2009 · 26 citations
    12. Effects of 17-β-Estradiol and ICI 182 780 on Hair Growth in Various Strains of Mice Journal of Investigative Dermatology Symposium Proceedings · 1999 · 32 citations
    13. Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions. PubMed · 2025
    14. Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective Evaluation Annals of Dermatology · 2017 · 6 citations
    15. Peculiar hypertrichosis in a patient affected by frontal fibrosing alopecia with pseudo "fringe sign" Giornale italiano di dermatologia e venereologia · 2020 · 2 citations
    16. Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil Journal of Clinical Medicine · 2023 · 1 citations
    17. Use of Topical Minoxidil, 17α-Estradiol and Hydrocortisone Butyrate in Frontal Fibrosing Alopecia European Journal of Inflammation · 2014 · 1 citations
    18. Association of hair dye use with circulating levels of sex hormones in premenopausal Japanese women European Journal of Public Health · 2015 · 6 citations
    19. A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia Journal of The American Academy of Dermatology · 2019 · 3 citations
    20. On Photo-Stability of Oxybenzone Journal of Investigative Dermatology · 1998 · 6 citations
    21. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism Journal of Steroid Biochemistry · 1975 · 232 citations
    22. Hormonal contraceptives: pharmacology tailored to women's health Human Reproduction Update · 2016 · 88 citations
    23. Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance Dermatologic Clinics · 2007 · 4 citations
    24. Non-classical Congenital Adrenal Hyperplasia Presenting With Severe Androgenic Alopecia: A Case Report Cureus · 2025
    25. Study on Changes of 19 Steroids in Plasma From 9 Diagnosed Patients With P450 Oxidoreductase Deficiency Research Square (Research Square) · 2021
    26. Androgens and Antiandrogens Annals of the New York Academy of Sciences · 2003 · 41 citations
    27. Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder The Journal of Sexual Medicine · 2019 · 11 citations
    28. Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression 2025 · 1 citations
    29. 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder The Journal of Sexual Medicine · 2019 · 1 citations
    30. Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior Physiology & Behavior · 2019 · 4 citations